Copper promotion of angiogenesis in isolated rat aortic ring: Role of vascular endothelial growth factor

Journal of Nutritional Biochemistry

Volumn 25, Issue 1, 2014, Pages 44-49

  Li, Qi feng ^a   Ding, Xue qin ^a   Kang, Y James ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Aortic ring; Copper; VEGF

Indexed keywords

AZAMETHONIUM; COPPER; TETRAETHYLENEPENTAMINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; THORACIC AORTA; VASCULAR RING;

ANGIOGENESIS; AORTIC RING; COPPER; VEGF;

ANIMALS; AORTA; CELL PROLIFERATION; COPPER; CULTURE MEDIA; ENDOTHELIAL CELLS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84889591958     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.08.013     Document Type: Article

References (23)

1. Ziche M., Jones J., Gullino P.M. Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 1982, 69:475-482.
2. Sen C.K., Khanna S., Venojarvi M., Trikha P., Ellison E.C., Hunt T.K., et al. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 2002, 282:H1821-H1827.
3. Jiang Y., Reynolds C., Xiao C., Feng W., Zhou Z., Rodriguez W., et al. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 2007, 204:657-666.
4. Zhou Y., Jiang Y., Kang Y.J. Copper inhibition of hydrogen peroxide-induced hypertrophy in embryonic rat cardiac H9c2 cells. Exp Biol Med (Maywood) 2007, 232:385-394.
5. Zhou Y., Jiang Y., Kang Y.J. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol 2008, 45:106-117.
6. Holderfield M.T., Hughes C.C. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res 2008, 102:637-652.
7. Shibuya M. Vascular endothelial growth factor-dependent and - independent regulation of angiogenesis. BMB Rep 2008, 41:278-286.
8. Li S., Xie H., Li S., Kang Y.J. Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway. Exp Biol Med 2012, 237:77-82.
9. Feng W., Ye F., Xue W., Zhou Z., Kang Y.J. Copper regulation of hypoxia inducible factor-1 activity. Mol Pharmacol 2009, 75:174-182.
10. Qiu L., Ding X., Zhang Z., Kang Y.J. Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1. JPET 2012, 342:561-567.
11. Wang G.L., Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 1993, 82:3610-3615.
12. 2-dependent degradation domain via the ubiquitinproteasome pathway. Proc Natl Acad Sci U S A 1998, 95:7987-7992.
13. Yuan Y., Hilliard G., Ferguson T., Millhorn D.E. Cobalt inhibits the interaction between hypoxia-inducible factor-1 and Von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-1. J Biol Chem 2003, 278:15911-15916.
14. Maxwell P., Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 2004, 3:29-35.
15. Ke Q., Kluz T., Costa M. Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line. Int J Environ Res Public Health 2005, 2:10-13.
16. HirsiläM, Koivunen P, Xu L, Seeley T, Kivirikko KI, and Myllyharju J, Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J 2005, 19:1308-10.
17. van Heerden D., Vosloo A., Nikinmaa M. Effects of short-term copper exposure on gill structure, metallothionein and hypoxia-inducible factor-1alpha (HIF-1alpha) levels in rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 2004, 69:271-280.
18. Martin F., Linden T., Katschinski D.M., Oehme F., Flamme I., Mukhopadhyay C.K., et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 2005, 105:4613-4619.
19. Conforti A., Franco L., Milanino R., Totorizzo A., Velo G.P. Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats. Br J Pharmac 1983, 79:45-52.
20. Ford E.S. Serum copper concentration and coronary heart disease among US adults. Am J Epidemiol 2000, 151:1182-1188.
21. Takimoto E., Champion H.C., Li M.X., Belardi D., Ren S.X., Rodriguez E.R., et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A preventsand reverses cardiac hypertrophy. Nat Med 2005, 11:214-222.
22. Koneru S., Varma Penumathsa S., Thirunavukkarasu M., Vidavalur R., Zhan L., Singal P.K., et al. Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1. J Cell Mol Med 2008, 12(6B):2651-2664.
23. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.